Bioscience

Emerging life sciences companies grabbing more in government grantsRestricted Content

August 10, 2009
Chris O'Malley
More emerging life science companies have found life in the form of federal Small Business Innovation Research grants.
More

Lilly cancels trials for experimental MS drug

July 28, 2009
J.K. Wall
Eli Lilly and Co. and a development partner has canceled clinical trials on an experimental drug to treat multiple sclerosis after the drug failed to delay progression of the disease in trial patients.
More

Dow Agrosciences introduces genetically modified corn seedRestricted Content

July 27, 2009
 IBJ Staff
Even after a string of acquisitions, Dow AgroSciences is a bit player in the seed business. But the new genetically modified corn it developed with St. Louis-based giant Monsanto Co. finally provides the breakthrough product that could grow its seed sales substantially.
More

Stem cell discovery promises health care revolutionRestricted Content

April 13, 2009
Bloomberg News
Scientists are using a new stem-cell technique that may someday revolutionize care for disorders as diverse as diabetes, Alzheimer's disease and muscular dystrophy.
More

Indiana playing trailblazing role in drive to tailor pharmaceuticals to genetic makeup of individualsRestricted Content

April 13, 2009
Chris O'Malley
Indiana is becoming not only a hotbed of "pharmacogenomics" research, but also a trailblazer in finding practical ways to use it on the practitioner level.
More

Executives make many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cellsRestricted Content

March 23, 2009
J.K. Wall
Eli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cells.
More

Biotech push may help offset generic competition; some analysts skepticalRestricted Content

February 2, 2009
J.K. Wall
Lilly executives want to make biotech their top focus.
More

Biotech venture fund in worksRestricted Content

January 5, 2009
Peter Schnitzler
BioCrossroads is setting the stage to create Indiana Future Fund II, an effort that would raise tens of millions of dollars for speculation on promising Hoosier life science companies.
More

Report sees jackpot with BioCrossroads, but expert sees obstaclesRestricted Content

February 4, 2008
J.K. Wall
Three months after launching an initiative to boost drug-development firms in Indiana, officials at BioCrossroads have written a report that attempts to show in detail the vast market opportunity they see.
More

IU takes statewide approach to life sciences pitchRestricted Content

January 21, 2008
J.K. Wall
For the last two months, two academics at Indiana University and Purdue University have been discussing how the institutions can work together to rev up research in medicine and life sciences and, in the process, boost Indiana's economy.
More

Ex-Lilly execs take on diabetes with Carmel startupRestricted Content

November 6, 2006
Peter Schnitzler
Four former top scientists at Eli Lilly and Co. have formed a Carmel-based company to develop diabetes therapies--a venture observers say has the potential to become the kind of blockbuster success BioCrossroads was built to stimulate.
More

Ex-prosecutor's lab biz builds network of government clientsRestricted Content

September 18, 2006
Tom Murphy
Labs are nearing capacity at Strand Analytical Laboratories, which provides forensic and paternity DNA testing. In the second year of Scott Newman's business, the former prosecutor predicts 2007 revenue will reach $4 million.
More
Page  << 1 2 3 pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. If what you stated is true, then this article is entirely inaccurate. "State sells bonds" is same as "State borrows money". Supposedly the company will "pay for them". But since we are paying the company, we are still paying for this road with borrowed money, even though the state has $2 billion in the bank.

  2. Andrew hit the nail on the head. AMTRAK provides terrible service and that is why the state has found a contractor to improve the service. More trips, on-time performance, better times, cleanliness and adequate or better restrooms. WI-FI and food service will also be provided. Transit from outlying areas will also be provided. I wouldn't take it the way it is but with the above services and marketing of the service,ridership will improve and more folks will explore Indy and may even want to move here.

  3. They could take the property using eminent domain and save money by not paying the church or building a soccer field and a new driveway. Ctrwd has monthly meetings open to all customers of the district. The meetings are listed and if the customers really cared that much they would show. Ctrwd works hard in every way they can to make sure the customer is put first. Overflows damage the surrounding environment and cost a lot of money every year. There have been many upgrades done through the years to help not send flow to Carmel. Even with the upgrades ctrwd cannot always keep up. I understand how a storage tank could be an eye sore, but has anyone thought to look at other lift stations or storage tanks. Most lift stations are right in the middle of neighborhoods. Some close to schools and soccer fields, and some right in back yards, or at least next to a back yard. We all have to work together to come up with a proper solution. The proposed solution by ctrwd is the best one offered so far.

  4. Fox has comments from several people that seem to have some inside information. I would refer to their website. Changed my whole opionion of this story.

  5. This place is great! I'm piggy backing and saying the Cobb salad is great. But the ribs are awesome. $6.49 for ribs and 2 sides?! They're delicious. If you work downtown, head over there.

ADVERTISEMENT